Articles

Association of HPV and p16 Status with Cetuximab plus Radiotherapy in Locally Advanced Head and Neck Cancer

ESMO 2014 – Gastrointestinal and Head & Neck Cancer

A Mutant-Selective EGFR Inhibitor in NSCLC

ASCO 2014 – Lung Cancer

Phase 2 Trial of Nivolumab and VEGF Inhibitors in First-Line Metastatic Renal Cell Carcinoma

ASCO 2014 – Immuno-Oncology

MPDL3280A, an Anti-PD-L1 Monoclonal Antibody, in Metastatic Bladder Cancer

ASCO 2014 – Immuno-Oncology

Pharmacokinetics of MEDI4736, an Anti-PD-L1 Monoclonal Antibody, in Advanced Solid Tumors

ASCO 2014 – Immuno-Oncology

Immuno-Oncology: The New Frontier?

ASCO 2014 – Immuno-Oncology

Ipilimumab Combined with Cytotoxic Chemotherapy in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology

Doublets and Triple Combinations in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology

Stereotactic Radiosurgery and Ipilimumab for Melanoma Brain Metastases

ASCO 2014 – Immuno-Oncology

Peginterferon alfa-2b Combined with Ipilimumab for Advanced Melanoma

ASCO 2014 – Immuno-Oncology

Page 141 of 147